IRF1 Inhibits Autophagy-Mediated Proliferation of Colorectal Cancer via Targeting ATG13

Cancer Invest. 2022 Jan;40(1):35-45. doi: 10.1080/07357907.2021.1961265. Epub 2021 Aug 17.

Abstract

IRF1 is a nuclear transcription factor that mediates interferon effects and appears to have anti-tumor activity. To determine the roles of IRF1 in colorectal cancer (CRC), we investigated the effects of IRF1 in CRC cells. We found that IRF1 inhibit cell proliferation and tumor growth. Under starvation conditions, IRF1 enhanced apoptosis and reduced autophagic flux. ATG13, an important factor of autophagy complex, was confirmed as a target of IRF1. These findings indicated that IRF1 function as a tumor suppressor in CRC and inhibit autophagy through ATG13, targeting this pathway may provide new insights into the molecular mechanisms of CRC progression.

Keywords: Colorectal cancer; IRF1; autophagy; growth.

MeSH terms

  • Animals
  • Autophagy / drug effects*
  • Autophagy-Related Proteins / metabolism*
  • Cell Proliferation
  • Colorectal Neoplasms / physiopathology*
  • Disease Models, Animal
  • Humans
  • Interferon Regulatory Factor-1 / pharmacology
  • Interferon Regulatory Factor-1 / therapeutic use*
  • Mice
  • Mice, Nude
  • Middle Aged
  • Transfection

Substances

  • ATG13 protein, human
  • Autophagy-Related Proteins
  • IRF1 protein, human
  • Interferon Regulatory Factor-1